| abstract |
The invention relates to compounds of formula (I), where R-R, A, B, n and m are as defined in the description of the invention. These new sulfonylamide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. The invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, in particular in humans, and to pharmaceutical compositions containing such compounds. |